Status:
COMPLETED
Tiotropium (18 Mcg) Once Daily Via the HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Pulmonary Disease, Chronic Obstructive
Eligibility:
All Genders
40+ years
Phase:
PHASE3
Brief Summary
The primary objective of this trial is to determine whether treatment with tiotropium (18 mcg) capsule once daily via the HandiHaler reduces the proportion of patients with COPD experiencing an exacer...
Eligibility Criteria
Inclusion
Exclusion
Key Trial Info
Start Date :
September 1 2001
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
1829 Patients enrolled
Trial Details
Trial ID
NCT00274547
Start Date
September 1 2001
Last Update
November 1 2013
Active Locations (26)
Enter a location and click search to find clinical trials sorted by distance.
1
Boehringer Ingelheim Investigational Site
Birmingham, Alabama, United States
2
Carl T. Hayden VA Medical Center
Phoenix, Arizona, United States
3
Southern Arizona VA Health Care System
Tuscon, Arizona, United States
4
VA Long Beach Healthcare System
Long Beach, California, United States